Torigen offers an autologous prescription product for dogs, cats and horses that uses the animal’s own tumor cells to create a personalized cancer immunotherapy. The treatment is a whole cell tissue vaccine, which works by generating specific adaptive immunity to tumor associated antigens found on the outside surface of tumor cells. It comes with a simple protocol that can be used alone in a general practice or in combination with chemotherapy and radiation. Torigen’s approach allows you to offer cancer treatment at an affordable price within your practice. More than 1,500 companion animals from over 500 clinics have been treated with Torigen’s autologous prescription product. https://www.torigen.com/
Bionote has a long history as a leading research and development company in the animal health diagnostic field. Headquartered in Minnesota, the Bionote USA team works with veterinarians and medical professionals around the world. The leadership team, including highly-experienced veterinary consultants, gives Bionote USA a unique presence in the animal care diagnostic field. Bionote’s forward-focused problem-solving approach to patient care resulted in the development of the Vcheck, an in-clinic, fluorescence immunoassay diagnostic analyzer, as well as its premium line of twelve diagnostic tests. The Vcheck analyzer uses europium-detection technology and is fully quantitative. Analyzers using europium-detection technology allow for greater separation in measuring wavelengths of general fluorescence for less overlap and more accuracy. These analyzers can often direct next steps and bridge the gap in diagnostic outcomes. Because tests do not need to be sent to a reference lab, there is also less potential for sample degradation.
Dechra’s companion animal portfolio focuses on endocrinology, oncology, dermatology, ophthalmology, anesthesia, fluid therapy, pain management, joint health support, and dental care. Our brands include Vetoryl® Capsules (trilostane), Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension), Felimazole® Coated Tablets (methimazole), the Vetivex® line of parenteral fluids, Isoflurane, USP Inhalant Anesthetic, Sevoflurane, USP Inhalant Anesthetic, and Phycox® joint health supplements. Osurnia® (florfenicol, terbinafine, betamethasone acetate) and the TrizUltra+Keto®, MiconaHex+Triz®, MalAcetic®, Atopivet™, and oral anti-infective product lines, including Marboquin® (marbofloxacin) Tablets and Amoxicillin and Clavulanate Potassium for Oral Suspension, spotlight the dermatology offerings. The addition of Mirataz® (mirtazapine transdermal ointment), Porus® One, and Redonyl® Ultra Feline to the portfolio supports the underserved feline market. Dechra also recently acquired the rights to the novel drugs Laverdia™-CA1 (verdinexor) and Zenalpha® (medetomidine and vatinoxan hydrochloridesinjection).
For more information, please visit www.dechra-us.com or call (866) 933-2472.
Plena Curae makes vet formulated botanical pain solutions sold exclusively to licensed professionals (DVM, VMD), never directly to clients on line. We offer 100% THC-free endocannabinoid support oils in high potency, palatable, easy-to-dose formulations, and micellar solubilized curcumin and boswellia extracts that are 185x more bioavailable than native curcumin. New in 2022— a renal support soft chew for chronic renal failure in cats, with active ingredients rehmennia and astragalus. Plena Curae is owned and formulated by Dr. Karen Gellman, well known holistic practitioner, researcher and educator, who can provide the science based support you need to safely, accurately and effectively manage your patients’ supplement needs.
You must be logged in to post a comment.